Overcoming negative predictions of microRNA expressions to gemcitabine response with FOLFIRINOX in advanced pancreatic cancer patients

FOLFIRINOX is superior to gemcitabine in patients with pancreatic cancer, but this regimen is associated with toxicity and biomarkers for response are warranted. MicroRNAs can mediate drug resistance and could provide predictive information. Altered expressions of several microRNAs including miR-21-...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlick, Konstantin, Hohla, Florian, Hamacher, Frank, Hackl, Hubert, Hufnagl, Clemens, Markus, Steiner, Magnes, Teresa, Gampenrieder, Simon Peter, Melchardt, Thomas, Stättner, Stefan, Hauser-Kronberger, Cornelia, Greil, Richard, Rinnerthaler, Gabriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Science Ltd 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787156/
https://www.ncbi.nlm.nih.gov/pubmed/33437513
http://dx.doi.org/10.2144/fsoa-2020-0128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787156/
https://www.ncbi.nlm.nih.gov/pubmed/33437513
http://dx.doi.org/10.2144/fsoa-2020-0128

Ejemplares similares